Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
NCT00167908Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2001
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of amifostine in xerostomia, sponsored by Washington University School of Medicine. Primary endpoint: Salivary function at 1 year. Started Oct 2001; status: completed.
02
Drugs
amifostine
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT00167908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167908.